Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);药物设计(Drug Design);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);人类(Humans);分子结构(Molecular Structure);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹唑啉酮类(Quinazolinones);构效关系(Structure-Activity Relationship);酪氨酸(Tyrosine);血管内皮生长因子受体2(Vascular Endothelial Growth Factor Receptor-2)
DOI
10.1080/07391102.2021.1890221
PMID
33682611
发布时间
2022-10-12
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文